FDA 483 to Favera, France Cites Gaps in
FDA has published the USFDA Form 483 issued to sterile drug manufacturing facility of Fareva
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
